How Can Good Research Practice Guidance Improve Health Technology Assessment?

Published Nov 6, 2017
Glasgow, Scotland, UK—6 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), focused on what aspects of health technology assessment (HTA) can be improved with good research practice guidance. The workshop, “Where Do We Need Good Research Practice Guidance in Health Technology Assessment?” [W1], was held this morning at the ISPOR 20th Annual European Congress in Glasgow, Scotland, UK. The session featured discussion leaders Finn Børlum Kristensen, MD, PhD, University of Southern Denmark, Hilleroed, Denmark; Mirjana Huić, MD, PhD, Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, Croatia; Wim Goettsch, PhD, The National Healthcare Institute, Diemen, The Netherlands; and Sophie Werkö, PhD, MSc, Swedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden. Post-regulatory approval evidence is increasingly informing population-based health care decisions. In this session, discussion leaders from the ISPOR Health Technology Assessment Council working group began with a global overview of existing good practices related to the translation of evidence to health care policy. Speakers then identified areas in which good research practice guidance is needed and how these areas might best be addressed at the European and global levels. The working group has conducted an overview of existing good practices related to translating evidence to policy from all regions of the world. The draft guidance document has already undergone two rounds of review, including a public review and comment stage. Additional information on the ISPOR 20th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the congress on social media using the hashtag #ISPORGlasgow.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×